In this episode of The Venari Podcast, Michael Paul discusses MARAbio's mission to mitigate the severe effects of autism.
Leveraging a ground-breaking discovery in immunology, MaraBio aims to detect, treat, and potentially prevent a subtype of autism caused by maternal autoantibodies. Paul shares his journey from research at Harvard Medical School to leading MaraBio, emphasizing the company's focus on precision medicine and the development of diagnostic tests to improve early intervention and outcomes for autism.